
Lupin Limited has informed the Exchange about press release dated 08-Jun-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Tablets.
Filed with NSE ·

Lupin Limited has informed the Exchange about press release dated 08-Jun-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Tablets.
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin